Consensus regarding multiple day and rescue antiemetic therapy

被引：8

作者：

De Mulder, PHM

Roila, F

Kris, MG

Marty, MM

机构：

[1] Univ Nijmegen Hosp, Dept Med Oncol, NL-6500 HB Nijmegen, Netherlands

[2] Div Med Oncol, Perugia, Italy

[3] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA

[4] Hop St Louis, Paris, France

来源：

SUPPORTIVE CARE IN CANCER | 1998年 / 6卷 / 03期

关键词：

chemotherapy; antiemetic therapy; rescue therapy; prophylaxis; multiple-day administration;

D O I：

10.1007/s005200050162

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Different forms of moderately and highly emetogenic cancer chemotherapy that are administered over several days per cycle are discussed with reference to the most efficacious antiemetic therapy. Both preventive and rescue antiemetic therapy are considered.

引用

收藏

页码：248 / 252

页数：5

相关论文

共 21 条

[1] ANTIEMETIC ACTIVITY OF HIGH-DOSE METOCLOPRAMIDE COMBINED WITH METHYLPREDNISOLONE VERSUS METOCLOPRAMIDE ALONE IN DACARBAZINE-TREATED CANCER-PATIENTS - A RANDOMIZED DOUBLE-BLIND-STUDY OF THE ITALIAN ONCOLOGY GROUP FOR CLINICAL RESEARCH [J].

BASURTO, C ;

ROILA, F ;

TONATO, M ;

BALLATORI, E ;

BUZZI, F ;

CALABRESI, F ;

DELFAVERO, A .

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1989, 12 (03) :235-238

[2] A SINGLE-BLIND STUDY OF THE EFFICACY AND SAFETY OF INTRAVENOUS GRANISETRON COMPARED WITH ALIZAPRIDE PLUS DEXAMETHASONE IN THE PROPHYLAXIS AND CONTROL OF EMESIS IN PATIENTS RECEIVING 5-DAY CYTOSTATIC THERAPY [J].

BREMER, K .

EUROPEAN JOURNAL OF CANCER, 1992, 28A (6-7) :1018-1022

[3]

BUSER KS, 1993, ANN ONCOL, V4, P474

[4] POSSIBLE LACK OF FULL CROSS-RESISTANCE OF 5HT(3) ANTAGONISTS - A PILOT-STUDY [J].

DEBOER, M ;

DEWIT, R ;

STOTER, G ;

VERWEIJ, J .

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1995, 121 (02) :126-127

[5]

DEPIERRE A, 1996, ANN ONCOL, V7, P134

[6]

DominguezOrtega L, 1996, CANCER, V77, P1566, DOI 10.1002/(SICI)1097-0142(19960415)77:8<1566::AID-CNCR21>3.0.CO

[7]

2-X

[8] ONDANSETRON - A NEW ANTIEMETIC FOR PATIENTS RECEIVING CISPLATIN CHEMOTHERAPY [J].

EINHORN, LH ;

NAGY, C ;

WERNER, K ;

FINN, AL .

JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (04) :731-735

[9]

FALKSON CI, 1995, ONCOLOGY, V52, P427

[10] ONDANSETRON VERSUS ONDANSETRON, DEXAMETHASONE, AND CHLORPROMAZINE IN THE PREVENTION OF NAUSEA AND VOMITING ASSOCIATED WITH MULTIPLE-DAY CISPLATIN CHEMOTHERAPY [J].

FOX, SM ;

EINHORN, LH ;

COX, E ;

POWELL, N ;

ABDY, A .

JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (12) :2391-2395